US20180050181A1 - Method of Using an Intra-Esophageal Balloon System - Google Patents
Method of Using an Intra-Esophageal Balloon System Download PDFInfo
- Publication number
- US20180050181A1 US20180050181A1 US15/786,707 US201715786707A US2018050181A1 US 20180050181 A1 US20180050181 A1 US 20180050181A1 US 201715786707 A US201715786707 A US 201715786707A US 2018050181 A1 US2018050181 A1 US 2018050181A1
- Authority
- US
- United States
- Prior art keywords
- balloon
- esophagus
- patient
- heart
- distal end
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 36
- 210000003238 esophagus Anatomy 0.000 claims abstract description 80
- 238000002679 ablation Methods 0.000 claims abstract description 46
- 210000005246 left atrium Anatomy 0.000 claims abstract description 25
- 208000014674 injury Diseases 0.000 claims abstract description 10
- 210000003105 phrenic nerve Anatomy 0.000 claims abstract description 10
- 239000007788 liquid Substances 0.000 claims description 13
- 230000006378 damage Effects 0.000 claims description 11
- 208000027418 Wounds and injury Diseases 0.000 claims description 8
- 238000013507 mapping Methods 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 2
- 238000005086 pumping Methods 0.000 claims 2
- 230000036760 body temperature Effects 0.000 claims 1
- 239000012530 fluid Substances 0.000 abstract description 21
- 210000000214 mouth Anatomy 0.000 abstract description 10
- 208000012260 Accidental injury Diseases 0.000 abstract description 2
- 206010003658 Atrial Fibrillation Diseases 0.000 description 16
- 239000000463 material Substances 0.000 description 9
- 230000001746 atrial effect Effects 0.000 description 6
- 230000003902 lesion Effects 0.000 description 5
- 239000002826 coolant Substances 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 210000003492 pulmonary vein Anatomy 0.000 description 4
- 208000006011 Stroke Diseases 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 238000005452 bending Methods 0.000 description 3
- 239000004020 conductor Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 208000006687 Esophageal Fistula Diseases 0.000 description 2
- 206010065835 Oesophageal fistula Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002837 heart atrium Anatomy 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000003685 thermal hair damage Effects 0.000 description 1
- 230000001515 vagal effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1018—Balloon inflating or inflation-control devices
- A61M25/10181—Means for forcing inflation fluid into the balloon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
- A61M29/02—Dilators made of swellable material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1047—Balloon catheters with special features or adapted for special applications having centering means, e.g. balloons having an appropriate shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1059—Balloon catheters with special features or adapted for special applications having different inflatable sections mainly depending on the response to the inflation pressure, e.g. due to different material properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1018—Balloon inflating or inflation-control devices
- A61M25/10184—Means for controlling or monitoring inflation or deflation
- A61M25/10185—Valves
Definitions
- the invention generally relates to atrial ablation procedures. More particularly, the invention relates to a method of moving a patient's esophagus away from an ablation site to prevent accidental damage to the esophagus during the performance of an ablation.
- Atrial fibrillation is the most common human arrhythmia.
- the incidence of atrial fibrillation increases with the age of the patient, and thus, the incidence of atrial fibrillation is becoming more prevalent as the average lifespan continue to increase.
- Atrial fibrillation is associated with increased morbidity and mortality and, in particular, a general decrease in quality of life for those afflicted with atrial fibrillation.
- Patients are at an increased risk of stroke unless they are treated adequately with anticoagulants.
- Anticoagulant treatment however, increases a patient's risk of bleeding, which carries with it its own set of dangers.
- Medications currently available for treating atrial fibrillation have proven to be only moderately effective in decreasing the incidence of recurrent atrial fibrillation, and these mediations do not decrease the patient's risk of having a stroke.
- ablating these areas of the left atrium serves to cure or prevent further incidences of atrial fibrillation, which thereby has shown to reduce the risk of stroke and reduce the necessity of anticoagulant therapy.
- ablations of this type are carried out via an intravascular catheter using radiofrequency or microwave energy to cause thermal damage to the selected parts of the left atrial tissue.
- the posterior wall of the left atrium is particularly targeted for ablation because the pulmonary veins enter the atrium at this area of the Left atrium.
- encircling the pulmonary veins with continuous rings of lesions is common in this procedure.
- the esophagus may however, be positioned so as to overlie one or more of these veins, thereby making the desired encirclement difficult or impossible.
- a significant and lethal complication of atrial fibrillation ablation is the accidental creation of an atrio-esophageal fistula following the development of lesions on the posterior wall of the left atrium.
- thermal injury may be communicated to the esophageal wall resulting in disruption of the wall and formation of the atria-esophageal fistula.
- fractionated electrograms and vagal plexi are also frequently present on the posterior wall of the left atrium. These are also common targets of atrial fibrillation ablation. Again, the location of the esophagus may hinder application. of a sufficient energy to successfully ablate enough tissue of the left atrium to prevent recurrence of atrial fibrillation. Further, the esophagus is a mobile structure. Thus, peristaltic movements thereof may cause the esophagus to move and change its position relative to the left atrium. Advanced intracardiac ultrasound systems that are used to locate the esophagus to prevent accidental damage thereto are often incapable of accounting for or tracking such movements, thus rendering these relatively complex and expensive systems ineffective.
- Fluoroscopic evaluation of the esophagus is also used to determine the position of the esophagus during ablation procedures like this however; such methods provide only two-dimensional information and thus may lead to misreading of the position of the esophagus as it relates to the left atrium.
- left atrial ablation of this kind also experiences a great deal of unwanted heat dissipation from the ablation catheter tip.
- the tissue immediately contiguous to the tip is heated, thereby disrupting cellular function thereof.
- a sufficient amount of heat must be generated to coagulate and denature the proteins in the myocardial cells. If a heat sink is present in close approximation of the ablation site, generating sufficient heat becomes difficult if not impossible using presently available RF generators. For instance, arteries in close approximation to the ablation site experience rapid blood flow sufficient to conduct heat away from the area rapidly.
- cryoablation and high frequency ultrasound are still considered experimental and are associated with particular disadvantages specific to these types of ablation.
- a device for moving the esophagus away from the left atrium of the heart is desired.
- a system for safely performing left atrial fibrillation ablation is provided.
- the system according to the invention is configured for selective movement of the esophagus away from the heart and the left atrium thereof such that the necessary areas of the left atrium may be ablated to prevent recurrent atrial fibrillation.
- the esophagus By moving the esophagus from the ablation site, the esophagus is maintained at a safe distance from the ablation site and in particular the ablation RF catheter such that the esophagus is not accidentally injured during the performance of the ablation procedure.
- the system of the invention includes an inflatable body, most typically a balloon, constructed primarily of a flexible material adapted for insertion into a patient's body through the oral cavity of the patient and into the esophagus.
- the balloon expands asymmetrically upon inflation to force the esophagus which contains the balloon to also bend and move away from the posterior wall of the atrium. Bending of the esophagus may be directed to also push the phrenic nerve away from the inferior pulmonary vein.
- the balloon may be inflated by a fluid such as air or another inert gas or, more preferably, by a liquid.
- Asymmetrical expansion may be facilitated by forming one strip or portion of the balloon from a material that has a relatively flexible portion and a remainder of the balloon from a relatively inflexible portion when viewed in transverse cross section. For example, a portion adjacent the patient's heart could be made relatively inflexible through the use of a stiffening strip. Because the stiff area of the balloon does not expand as much as the remainder of the balloon, the area of the esophagus adjacent thereto is not contacted by the balloon at this area.
- the inflexible portion of the balloon preferably is positioned in the esophagus adjacent the left atrium of the heart such that this portion of the esophagus remains a sufficient distance away from the left atrium such that, upon inflation of the balloon, the balloon is inflated and the esophagus bends away from the area of the left atrium to be ablated
- the system may include a relief valve for selective expulsion of excess fluid therefrom.
- a liquid used to inflate the balloon may be radio-opaque so as not to interfere with imaging of the esophagus and/or heart with X-ray or fluoroscopic examination and/or may be cooled to act as a heat sink during ablation.
- a number of electrodes are embedded, attached, or otherwise coupled to the wall of the balloon and interconnected by way of a conductor to an electrical power source.
- the electrodes may communicate with a 3D mapping system such that the location of the esophagus vis-a-vis the electrodes can be determined such that the operator may assess the position of the esophagus while performing the ablation procedures,
- one or more magnetic dipoles may be provided in communication with a magnetically operated 3D mapping system to operate in much the same manner.
- One or more temperature sensors also may be provided for monitoring the effects of the ablation procedure on the esophagus.
- FIG. 1 is a schematic illustration of a patient having an intra-esophageal balloon system constructed in accordance with a preferred embodiment the invention inserted into the patient's esophagus;
- FIG. 2 is a partially cut away isometric view corresponding to FIG. 1 ;
- FIG. 3 is a side elevation view of part of a balloon of the intra-esophageal balloon of the system of FIGS. 1 and 2 , showing the balloon in a deflated state;
- FIG. 4 is a side el elevation view of the balloon of FIG. 3 , showing the balloon in an inflated state;
- FIG. 5 is a side sectional elevation view of the balloon in its inflated state of FIG. 4 .
- FIG. 6 is an end sectional elevation view of the balloon of the invention.
- FIG. 7 is a schematic representation of the intra-esophageal balloon system of FIGS. 1 and 2 ;
- FIG. 8 is an end sectional elevation view of a balloon constructed in accordance with an alternative embodiment of the invention.
- FIG. 1 a schematic illustration of a portion of the internal organs of a patient 10 is provided with an intra-esophageal balloon system 20 constructed in accordance with a preferred embodiment of the invention inserted therein.
- Patient 10 has a mouth 12 leading to the esophagus 14 , which then terminates at an opening of the stomach 16 .
- the esophagus 14 is in close proximity to patient's heart 18 , placing the esophagus at risk to injury during left atrial ablation.
- the intra-esophageal balloon system 20 is inserted through the patient's mouth 12 and oral cavity 13 and into the esophagus 14 .
- a balloon 22 of the system 20 is positioned within the esophagus 14 at a point substantially lateral to a left atrium 24 of the heart 18 .
- Balloon 22 comprises a proximal or upper end 26 and a distal or lower end 28 opposite proximal end 26 .
- Proximal end 26 is interconnected with a tube 30 that extends upwardly through the esophagus 14 and through patient's mouth 12 to a source of pressurized liquid, shown at 40 in FIG. 6 and described in detail below.
- the balloon 22 is designed to expand asymmetrically when inflated by fluid from the source 38 , 40 ( FIG. 7 ) to bend, distort, or otherwise move the esophagus 14 away from the heart 18 and facilitate left atrial ablation without thermal injury to the esophagus.
- the balloon 22 When inflated in the absence of an obstruction such as in the open air, the balloon 22 expands at least 5% more, and preferably 15% more on one side of a longitudinal bisector “B” of the balloon 22 than the other side.
- Balloon 22 may be configured to be inflated to pressures of approximately 8-10 atmospheres. When balloon 22 is inflated, balloon 22 may be 4-7 cm long and less than or equal to 2 cm in diameter, although alternative ranges are envisioned and are within the scope of the present invention.
- a relief valve 32 is disposed at the distal end 28 of the balloon 22 to prevent its over-inflation.
- the balloon 22 preferably is inflated with a liquid such as saline, admixed with radiopaque contrast material, although air or another inert gas could be used to inflate balloon 22 .
- balloon 22 comprises an elongate, relatively narrow balloon constructed of silicone, rubber or a similar flexible material that may be safely introduced into the esophagus
- balloon 22 is generally circular cross-section when uninflated so as to be symmetrical about a longitudinal bisector B, though it is contemplated that the balloon 22 may be more ovoid or have other shapes, so long as the balloon can be inserted into the patient's esophagus 14 in its deflated state and inflated as discussed below.
- balloon 22 is configured to expand asymmetrically when inflated so as to distort the esophagus 14 away from the heart 18 .
- Asymmetrical expansion may be made possible by rendering the balloon circumferentially non-uniformly flexible. This effect is most easily achieved by making at least one side or edge portion of the balloon more or less flexible than at least one other side or edge portion of the balloon.
- this capability is enabled by providing a longitudinally-extending stiffening strip 34 along a side portion thereof.
- Stiffening strip 34 is constructed of a material that is substantially more rigid than the remainder of the material of which balloon 22 is constructed, such as a relatively hard plastic material. Stiffening strip 34 is mounted on, in, or integrally formed with the remainder of the balloon 22 .
- Stiffening strip 34 preferably is applied along one relatively peripheral narrow portion of balloon 22 at a location at or near the portion of the esophagus 14 that is closest to the patient's heart 18 and extends lengthwise from proximal end 26 to distal end 28 without extending distally beyond the distal end.
- Stiffening strip 34 preferably has a width similar to that of an average width of a patient's esophagus for reasons that will be made apparent from the ensuing description.
- stiffening strip 34 may have a width of approximately 1 mm to 2 cm.
- stiffening strip 34 is configured to inhibit or prevent a portion of balloon 22 from expanding during inflation of balloon 22 .
- Stiffening strip 34 may be a wire or piece of fishing line embedded into or attached to a wall of balloon 22 , Stiffening strip 34 is shown as being embedded in the wall of balloon 22 in FIGS. 1-6 .
- the stiffening strip 34 ′ is mounted to an exterior of the balloon 22 ′. In both embodiments, the entire inner circumference of the balloon is constructed from a flexible material.
- stiffening strip 34 has a radiopaque marker affixed to it to identify the location of the stiffening strip 34 when using imaging equipment. In this manner, balloon 22 may be oriented under fluoroscopy or other imaging techniques to ensure proper positioning of stiffening strip 34 with respect to the esophagus 14 .
- balloon 22 is configured to be inflated by way of a fluid or preferably a liquid that is introduced through tube 30 . Because the tube 30 has an outlet terminating at an inlet of the balloon 22 as seen in FIG. 5 , no structures extend completely through the balloon between the proximal and distal ends thereof, as can be clearly seen in. FIG. 5 . In addition, since the distal end of the tube 20 terminates at the proximal end of the balloon 22 , stiffening strip 34 extends beneath the distal end of the tube 20 , again as clearly illustrated in FIG. 5 . As the liquid is introduced into balloon 22 , balloon 22 begins to inflate and expand around the portions constructed from the flexible material.
- the portion of balloon 22 incorporating the stiffening strip 34 will expand less than the remainder of the balloon, if at all.
- the resultant inflation of balloon 22 in a non-uniform or asymmetrical manner causes the balloon 22 to bend or bow relative to the longitudinal bisector B of the uninflated result.
- the balloon distorts from the uninflated state shown in FIGS. 1 and 3 in which the balloon 22 extends linearly as a whole and is symmetrical about the longitudinal bisector B.
- the balloon as a whole extends significantly non-linearly so that the curvature of the balloon as whole, including the stiffening strip 34 , is substantially increased in a common direction relative to the longitudinal bisector B of the uninflated balloon 22 .
- the resulting high curvature is especially evident in FIG. 2 , in which the balloon 22 is shown as having a generally crescent shape when viewed in profile.
- the bending of the balloon 22 as a whole moves the esophagus 14 away from the patient's heart as can been in FIG, 2 .
- the bending increases progressively from the ends of the balloon towards its center such that esophageal distortion is maximized at or near the ablation site.
- stiffening strip could be used instead of or in addition to cause asymmetrical inflation.
- stiffness of a strip of the balloon extending along the side of the balloon opposite the heart could be reduced, e.g., by reducing its thickness.
- This “reduced stiffness strip” could be provided instead of or in addition to a stiffening strip at the opposite side of the balloon near the heart.
- Either strip could have varying stiffening or weakening properties at different locations along its length so as to tailor the location of maximum asymmetrical distortion to a desired portion of the balloon 22 .
- Either strip could be continuous and extend at least generally the entire length of the balloon as illustrated, or could extend along only along part of the length of the balloon 22 , as a continuous strip or in discrete aligned or misaligned segments.
- strips of reduced and/or enhanced stiffness could be provided along portion(s) of the balloon that are between the side adjacent the heart and the side opposite the heart, causing the balloon to bend sideways away from the ablation site.
- Relief valve 32 is configured to prevent over-inflation of balloon 22 and resultant possible injury to esophagus 14 by preventing the fluid pressure in the balloon from exceeding a certain predetermined level.
- Relief valve 32 can be any kind of relief valve generally known in the art that simply opens at the threshold pressure to release the excess liquid into the esophagus 14 and the stomach 16 and that automatically closes when the pressure in the balloon 22 drops below the predetermined pressure.
- the predetermined pressure preferably is settable using suitable controls located on or in the valve 32 .
- balloon 22 is coupled to tube 30 at the proximal end 26 thereof.
- Tube 30 extends upwardly from balloon 22 through the oral cavity and out of mouth 12 .
- An inner lumen of balloon 22 is continuous with the lumen of tube 30 to thereby prevent leaking of fluid from tube 30 .
- Tube 30 preferably is constructed from a relatively flexible medical grade material that is compatible with insertion into a patient and is generally cylindrical in shape.
- the opposite end of tube 30 is connected to a liquid delivery device, such as a pump 38 , shown schematically in FIG. 7 .
- Tube 30 and pump 38 may be coupled by way of a stopcock, valve, or similar such interconnection permitting the selected supply of pressurized fluid to the balloon 22 .
- a pressure reducer and/or pressure regulator may be provided within the pump 38 or between the pump 38 and the balloon 22 to supplement or even replace the relief valve 32 .
- Pump 38 may be a mechanical or electrical pump. Pump 38 is connected to a reservoir 40 holding a quantity of fluid for delivery to balloon 22 .
- the fluid held in reservoir 40 is cooled to promote esophageal cooling during ablation.
- reservoir 40 may hold iced saline or a similar such biocompatible fluid.
- the fluid held in reservoir 40 is a radiopaque coolant fluid.
- the tube 30 and balloon 22 serve to provide a so-called heat-sink to further reduce the risk of perforating or otherwise damaging the esophagus during ablation of the heart 18 .
- the coolant also preferably is radiopaque, such as having been treated with a radiopaque dye of the kind known in the art.
- the esophagus 14 is readily visible using X-rays or other imaging techniques while the fluid is flowing through the tube 30 while tube 30 is inserted into the esophagus 14 .
- the operator carrying out the procedure is able to view the esophagus 14 during inflation of balloon 22 such that he or she may better observe the location of the esophagus 14 with respect to the heart 18 and, in particular, the left atrium 24 of the heart.
- the operator is able to determine whether esophagus 14 has been moved sufficiently far from the heart 18 such that he or she may safely perform an ablation thereon.
- a radio-opaque fluid also permits the ablation process to be imaged without obstruction from the balloon 22 .
- Electrodes 42 are inserted into the balloon 22 via tube 30 .
- electrodes 42 are disposed within the wall of balloon 22 .
- Electrodes 42 are coupled to a power source 44 (see FIG. 7 ) by way of an electrical conductor 46 , which extends upwardly through tube 30 and out of the tube 30 for interconnection with power source 44 .
- Power source 44 may be an electrical connection assembly of the kind known in the art configured to supply a predetermined amount of electricity to the electrodes 42 .
- the electrodes 42 by way of conductor 46 may be interfaced with a three-dimensional electro-anatomical mapping system of the kind generally known in the art.
- balloon 22 is capable of being viewed by the operator at a display screen in three-dimensions.
- balloon 22 may be viewed in relation to the ablation site on heart 18 at any given time.
- electrodes 42 may be replaced by magnetic dipoles that allow the location of the balloon 22 to be detected using a magnetically-based three-dimensional mapping system such as CARTO 3D or a similar known system.
- balloon 22 may include a number of temperature sensors 47 incorporated into the balloon 22 cavity or wall.
- the temperature sensors may be interconnected with a temperature monitoring assembly such that the operator may be able to determine a temperature of the balloon 22 during ablation of left atrium 24 of heart 18 .
- the system 20 of the invention may be configured to automatically respond.
- system 20 may be configured to respond to prevent a lesion from forming or expanding by flooding the balloon 22 with additional fluid When a particular predetermined temperature is detected.
- the system 20 may be interfaced with the power source of the ablation mechanism such that the ablation itself is also terminated.
- balloon 22 is introduced into the esophagus 14 through the oral cavity 13 via the mouth 12 to a location in which it is substantially adjacent to, and preferably parallel with, the left atrium 24 of heart 18 , It is positioned such that the stiffening strip 34 is located adjacent a portion of the esophagus that is relatively close to the heart. Accordingly, when balloon 22 is inflated asymmetrically but circumferentially, the adjacent portion of the esophagus 14 will be moved away from the heart 18 . More specifically, the operator actuates pump 38 and/or related controls to supply pressurized fluid into the tube 30 and thence into balloon 22 .
- the balloon 22 expands asymmetrically in the direction of the flexible portion 48 thereof
- the expansion of the flexible portion 48 of balloon 22 causes the balloon 22 to bow or bend in the direction of the expansion, eventually contacting the sidewall of the esophagus adjacent thereto.
- the flexible portion 48 continues to expand, it begins to exert a force on the esophagus 14 such that esophagus 14 moves in a direction of the applied force or away from the heart 18 . In this manner, as can best be seen from FIG.
- the esophagus becomes bowed at or about the region adjacent heart 18 to move directly away from or sideways relative to the left atrium such that the caregiver is free to begin the ablation of left atrium 24 of heart 18 .
- the balloon 22 is configured and oriented such that, when the balloon is inflated, the esophagus 14 moves sideways away from the ablation site to interpose itself between the phrenic nerve and the left atrial lesion, the esophagus 14 can provide a barrier or protection against accidental damage to the phrenic nerve.
- the esophagus preferably moves at least 5 mm, and more preferably at least 20 mm, laterally away from its initial position.
- the coolant in the balloon 22 also serves as a heat sink sufficient to mitigate or even prevent injury to the phrenic nerve, or balloon 22 may assist in mobilizing the nerve such that it is positioned out of the way of the ablation site.
- the balloon 22 is deflated by operation of the relief valve 32 or otherwise and removed from the esophagus.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
- This application is a divisional of U.S. pat. app. Ser. No, 12/847,018, filed Jul. 30, 2010 and entitled INTRA-ESOPHAGEAL BALLOON SYSTEM, which claims priority from U.S. Provisional Patent Application Ser. No. 61/272,564, filed on Oct. 6, 2009, the entire contents of each of which is hereby expressly incorporated by reference into the present application in its entirety.
- The invention generally relates to atrial ablation procedures. More particularly, the invention relates to a method of moving a patient's esophagus away from an ablation site to prevent accidental damage to the esophagus during the performance of an ablation.
- Atrial fibrillation is the most common human arrhythmia. The incidence of atrial fibrillation increases with the age of the patient, and thus, the incidence of atrial fibrillation is becoming more prevalent as the average lifespan continue to increase. Atrial fibrillation is associated with increased morbidity and mortality and, in particular, a general decrease in quality of life for those afflicted with atrial fibrillation. Patients are at an increased risk of stroke unless they are treated adequately with anticoagulants. Anticoagulant treatment however, increases a patient's risk of bleeding, which carries with it its own set of dangers. Medications currently available for treating atrial fibrillation have proven to be only moderately effective in decreasing the incidence of recurrent atrial fibrillation, and these mediations do not decrease the patient's risk of having a stroke.
- One method of treating atrial fibrillation has been to perform ablation of selected areas of the left atrium. There is evidence to suggest that ablating these areas of the left atrium serves to cure or prevent further incidences of atrial fibrillation, which thereby has shown to reduce the risk of stroke and reduce the necessity of anticoagulant therapy. Typically, ablations of this type are carried out via an intravascular catheter using radiofrequency or microwave energy to cause thermal damage to the selected parts of the left atrial tissue.
- The posterior wall of the left atrium is particularly targeted for ablation because the pulmonary veins enter the atrium at this area of the Left atrium. Thus, encircling the pulmonary veins with continuous rings of lesions is common in this procedure. The esophagus may however, be positioned so as to overlie one or more of these veins, thereby making the desired encirclement difficult or impossible. A significant and lethal complication of atrial fibrillation ablation is the accidental creation of an atrio-esophageal fistula following the development of lesions on the posterior wall of the left atrium. Because the esophagus is generally closely positioned to the posterior wall of the left atrium, thermal injury may be communicated to the esophageal wall resulting in disruption of the wall and formation of the atria-esophageal fistula.
- In addition to the foregoing, fractionated electrograms and vagal plexi are also frequently present on the posterior wall of the left atrium. These are also common targets of atrial fibrillation ablation. Again, the location of the esophagus may hinder application. of a sufficient energy to successfully ablate enough tissue of the left atrium to prevent recurrence of atrial fibrillation. Further, the esophagus is a mobile structure. Thus, peristaltic movements thereof may cause the esophagus to move and change its position relative to the left atrium. Advanced intracardiac ultrasound systems that are used to locate the esophagus to prevent accidental damage thereto are often incapable of accounting for or tracking such movements, thus rendering these relatively complex and expensive systems ineffective. Fluoroscopic evaluation of the esophagus is also used to determine the position of the esophagus during ablation procedures like this however; such methods provide only two-dimensional information and thus may lead to misreading of the position of the esophagus as it relates to the left atrium.
- In addition to the foregoing disadvantages, left atrial ablation of this kind also experiences a great deal of unwanted heat dissipation from the ablation catheter tip. Upon application of the catheter tip to the ablation site, the tissue immediately contiguous to the tip is heated, thereby disrupting cellular function thereof. A sufficient amount of heat must be generated to coagulate and denature the proteins in the myocardial cells. If a heat sink is present in close approximation of the ablation site, generating sufficient heat becomes difficult if not impossible using presently available RF generators. For instance, arteries in close approximation to the ablation site experience rapid blood flow sufficient to conduct heat away from the area rapidly.
- Other methods, such as cryoablation and high frequency ultrasound, are still considered experimental and are associated with particular disadvantages specific to these types of ablation.
- It has recently been discovered that successful atrial fibrillation ablation may require the introduction of lesions near the location of the inferior right pulmonary vein, which is located in close proximity to the phrenic nerve. Thus, it is has become more common for accidental injury to the phrenic nerve to occur. The phrenic nerve is responsible for operation of the diaphragm, and thus, injury to the phrenic nerve can be quite catastrophic. Thus, a method or system for preventing such injuries is deemed highly desirable.
- The need therefore exists to provide a device for carrying out atrial fibrillation ablation of the left atrium that does not suffer from the foregoing disadvantages. In particular, a device for moving the esophagus away from the left atrium of the heart is desired.
- In accordance with a first aspect of the invention, a system for safely performing left atrial fibrillation ablation is provided. In particular, the system according to the invention is configured for selective movement of the esophagus away from the heart and the left atrium thereof such that the necessary areas of the left atrium may be ablated to prevent recurrent atrial fibrillation. By moving the esophagus from the ablation site, the esophagus is maintained at a safe distance from the ablation site and in particular the ablation RF catheter such that the esophagus is not accidentally injured during the performance of the ablation procedure.
- The system of the invention includes an inflatable body, most typically a balloon, constructed primarily of a flexible material adapted for insertion into a patient's body through the oral cavity of the patient and into the esophagus. The balloon expands asymmetrically upon inflation to force the esophagus which contains the balloon to also bend and move away from the posterior wall of the atrium. Bending of the esophagus may be directed to also push the phrenic nerve away from the inferior pulmonary vein. The balloon may be inflated by a fluid such as air or another inert gas or, more preferably, by a liquid.
- Asymmetrical expansion may be facilitated by forming one strip or portion of the balloon from a material that has a relatively flexible portion and a remainder of the balloon from a relatively inflexible portion when viewed in transverse cross section. For example, a portion adjacent the patient's heart could be made relatively inflexible through the use of a stiffening strip. Because the stiff area of the balloon does not expand as much as the remainder of the balloon, the area of the esophagus adjacent thereto is not contacted by the balloon at this area. Thus, the inflexible portion of the balloon preferably is positioned in the esophagus adjacent the left atrium of the heart such that this portion of the esophagus remains a sufficient distance away from the left atrium such that, upon inflation of the balloon, the balloon is inflated and the esophagus bends away from the area of the left atrium to be ablated
- The system may include a relief valve for selective expulsion of excess fluid therefrom.
- A liquid used to inflate the balloon may be radio-opaque so as not to interfere with imaging of the esophagus and/or heart with X-ray or fluoroscopic examination and/or may be cooled to act as a heat sink during ablation.
- In one embodiment of the invention, a number of electrodes are embedded, attached, or otherwise coupled to the wall of the balloon and interconnected by way of a conductor to an electrical power source. The electrodes may communicate with a 3D mapping system such that the location of the esophagus vis-a-vis the electrodes can be determined such that the operator may assess the position of the esophagus while performing the ablation procedures, In addition to or instead of the electrodes, one or more magnetic dipoles may be provided in communication with a magnetically operated 3D mapping system to operate in much the same manner. One or more temperature sensors also may be provided for monitoring the effects of the ablation procedure on the esophagus.
- Various other features, embodiments and alternatives of the present invention will be made apparent from the following detailed description taken together with the drawings. It should be understood, however, that the detailed description and specific examples, While indicating preferred embodiments of the invention, are given by way of illustration and not limitation. Many changes and modifications could be made within the scope of the present invention without departing from the spirit thereof, and the invention includes all such modifications.
- In the Drawings:
-
FIG. 1 is a schematic illustration of a patient having an intra-esophageal balloon system constructed in accordance with a preferred embodiment the invention inserted into the patient's esophagus; -
FIG. 2 is a partially cut away isometric view corresponding toFIG. 1 ; -
FIG. 3 is a side elevation view of part of a balloon of the intra-esophageal balloon of the system ofFIGS. 1 and 2 , showing the balloon in a deflated state; -
FIG. 4 is a side el elevation view of the balloon ofFIG. 3 , showing the balloon in an inflated state; -
FIG. 5 is a side sectional elevation view of the balloon in its inflated state ofFIG. 4 . -
FIG. 6 is an end sectional elevation view of the balloon of the invention; -
FIG. 7 is a schematic representation of the intra-esophageal balloon system ofFIGS. 1 and 2 ; and -
FIG. 8 is an end sectional elevation view of a balloon constructed in accordance with an alternative embodiment of the invention. - Preferred exemplary embodiments of the invention are illustrated in the accompanying drawings, in which like reference numerals represent like parts throughout, and in which:
- Referring now to the drawings, and initially
FIG. 1 , a schematic illustration of a portion of the internal organs of a patient 10 is provided with anintra-esophageal balloon system 20 constructed in accordance with a preferred embodiment of the invention inserted therein. Patient 10 has a mouth 12 leading to the esophagus 14, which then terminates at an opening of thestomach 16. The esophagus 14 is in close proximity to patient'sheart 18, placing the esophagus at risk to injury during left atrial ablation. - The
intra-esophageal balloon system 20 is inserted through the patient's mouth 12 and oral cavity 13 and into the esophagus 14. In particular, aballoon 22 of thesystem 20 is positioned within the esophagus 14 at a point substantially lateral to a left atrium 24 of theheart 18,Balloon 22 comprises a proximal or upper end 26 and a distal orlower end 28 opposite proximal end 26. Proximal end 26 is interconnected with a tube 30 that extends upwardly through the esophagus 14 and through patient's mouth 12 to a source of pressurized liquid, shown at 40 inFIG. 6 and described in detail below. Theballoon 22 is designed to expand asymmetrically when inflated by fluid from the source 38, 40 (FIG. 7 ) to bend, distort, or otherwise move the esophagus 14 away from theheart 18 and facilitate left atrial ablation without thermal injury to the esophagus. When inflated in the absence of an obstruction such as in the open air, theballoon 22 expands at least 5% more, and preferably 15% more on one side of a longitudinal bisector “B” of theballoon 22 than the other side.Balloon 22 may be configured to be inflated to pressures of approximately 8-10 atmospheres. Whenballoon 22 is inflated,balloon 22 may be 4-7 cm long and less than or equal to 2 cm in diameter, although alternative ranges are envisioned and are within the scope of the present invention. A relief valve 32 is disposed at thedistal end 28 of theballoon 22 to prevent its over-inflation. Theballoon 22 preferably is inflated with a liquid such as saline, admixed with radiopaque contrast material, although air or another inert gas could be used to inflateballoon 22. - Referring now to
FIGS. 3-6 ,balloon 22 comprises an elongate, relatively narrow balloon constructed of silicone, rubber or a similar flexible material that may be safely introduced into the esophagus, With momentary reference toFIG. 6 ,balloon 22 is generally circular cross-section when uninflated so as to be symmetrical about a longitudinal bisector B, though it is contemplated that theballoon 22 may be more ovoid or have other shapes, so long as the balloon can be inserted into the patient's esophagus 14 in its deflated state and inflated as discussed below. - As mentioned briefly above,
balloon 22 is configured to expand asymmetrically when inflated so as to distort the esophagus 14 away from theheart 18. Asymmetrical expansion may be made possible by rendering the balloon circumferentially non-uniformly flexible. This effect is most easily achieved by making at least one side or edge portion of the balloon more or less flexible than at least one other side or edge portion of the balloon. In the illustrated embodiment, this capability is enabled by providing a longitudinally-extendingstiffening strip 34 along a side portion thereof. Stiffeningstrip 34 is constructed of a material that is substantially more rigid than the remainder of the material of whichballoon 22 is constructed, such as a relatively hard plastic material. Stiffeningstrip 34 is mounted on, in, or integrally formed with the remainder of theballoon 22. Stiffeningstrip 34 preferably is applied along one relatively peripheral narrow portion ofballoon 22 at a location at or near the portion of the esophagus 14 that is closest to the patient'sheart 18 and extends lengthwise from proximal end 26 todistal end 28 without extending distally beyond the distal end. Stiffeningstrip 34 preferably has a width similar to that of an average width of a patient's esophagus for reasons that will be made apparent from the ensuing description. In particular, stiffeningstrip 34 may have a width of approximately 1 mm to 2 cm. In particular, as can be best seen inFIG. 4 , stiffeningstrip 34 is configured to inhibit or prevent a portion ofballoon 22 from expanding during inflation ofballoon 22. Stiffeningstrip 34 may be a wire or piece of fishing line embedded into or attached to a wall ofballoon 22, Stiffeningstrip 34 is shown as being embedded in the wall ofballoon 22 inFIGS. 1-6 . In an alternative embodiment, shown inFIG. 8 , the stiffeningstrip 34′ is mounted to an exterior of theballoon 22′. In both embodiments, the entire inner circumference of the balloon is constructed from a flexible material. In one embodiment, stiffeningstrip 34 has a radiopaque marker affixed to it to identify the location of thestiffening strip 34 when using imaging equipment. In this manner,balloon 22 may be oriented under fluoroscopy or other imaging techniques to ensure proper positioning of stiffeningstrip 34 with respect to the esophagus 14. - As will be explained in detail,
balloon 22 is configured to be inflated by way of a fluid or preferably a liquid that is introduced through tube 30. Because the tube 30 has an outlet terminating at an inlet of theballoon 22 as seen inFIG. 5 , no structures extend completely through the balloon between the proximal and distal ends thereof, as can be clearly seen in.FIG. 5 . In addition, since the distal end of thetube 20 terminates at the proximal end of theballoon 22, stiffeningstrip 34 extends beneath the distal end of thetube 20, again as clearly illustrated inFIG. 5 . As the liquid is introduced intoballoon 22,balloon 22 begins to inflate and expand around the portions constructed from the flexible material. On the other hand, the portion ofballoon 22 incorporating thestiffening strip 34 will expand less than the remainder of the balloon, if at all. The resultant inflation ofballoon 22 in a non-uniform or asymmetrical manner causes theballoon 22 to bend or bow relative to the longitudinal bisector B of the uninflated result. As a result of this, the balloon distorts from the uninflated state shown inFIGS. 1 and 3 in which theballoon 22 extends linearly as a whole and is symmetrical about the longitudinal bisector B. When theballoon 22 is in the inflated state shown inFIGS. 2 and 4 , the balloon as a whole extends significantly non-linearly so that the curvature of the balloon as whole, including thestiffening strip 34, is substantially increased in a common direction relative to the longitudinal bisector B of theuninflated balloon 22. The resulting high curvature is especially evident inFIG. 2 , in which theballoon 22 is shown as having a generally crescent shape when viewed in profile. The bending of theballoon 22 as a whole moves the esophagus 14 away from the patient's heart as can been in FIG, 2. The bending increases progressively from the ends of the balloon towards its center such that esophageal distortion is maximized at or near the ablation site. - Other mechanisms could be used instead of or in addition to the stiffening strip to cause asymmetrical inflation. For example, the stiffness of a strip of the balloon extending along the side of the balloon opposite the heart could be reduced, e.g., by reducing its thickness. This “reduced stiffness strip” could be provided instead of or in addition to a stiffening strip at the opposite side of the balloon near the heart. Either strip could have varying stiffening or weakening properties at different locations along its length so as to tailor the location of maximum asymmetrical distortion to a desired portion of the
balloon 22. Either strip could be continuous and extend at least generally the entire length of the balloon as illustrated, or could extend along only along part of the length of theballoon 22, as a continuous strip or in discrete aligned or misaligned segments. Alternatively, strips of reduced and/or enhanced stiffness could be provided along portion(s) of the balloon that are between the side adjacent the heart and the side opposite the heart, causing the balloon to bend sideways away from the ablation site. - Relief valve 32 is configured to prevent over-inflation of
balloon 22 and resultant possible injury to esophagus 14 by preventing the fluid pressure in the balloon from exceeding a certain predetermined level. Relief valve 32 can be any kind of relief valve generally known in the art that simply opens at the threshold pressure to release the excess liquid into the esophagus 14 and thestomach 16 and that automatically closes when the pressure in theballoon 22 drops below the predetermined pressure. The predetermined pressure preferably is settable using suitable controls located on or in the valve 32. - Referring now to
FIGS. 1-7 , opposite the relief valve 32,balloon 22 is coupled to tube 30 at the proximal end 26 thereof. Tube 30 extends upwardly fromballoon 22 through the oral cavity and out of mouth 12. An inner lumen ofballoon 22 is continuous with the lumen of tube 30 to thereby prevent leaking of fluid from tube 30. Tube 30 preferably is constructed from a relatively flexible medical grade material that is compatible with insertion into a patient and is generally cylindrical in shape. The opposite end of tube 30 is connected to a liquid delivery device, such as a pump 38, shown schematically inFIG. 7 . Tube 30 and pump 38 may be coupled by way of a stopcock, valve, or similar such interconnection permitting the selected supply of pressurized fluid to theballoon 22. A pressure reducer and/or pressure regulator may be provided within the pump 38 or between the pump 38 and theballoon 22 to supplement or even replace the relief valve 32. - Pump 38 may be a mechanical or electrical pump. Pump 38 is connected to a reservoir 40 holding a quantity of fluid for delivery to balloon 22. Preferably, the fluid held in reservoir 40 is cooled to promote esophageal cooling during ablation. In particular, reservoir 40 may hold iced saline or a similar such biocompatible fluid. In a preferred embodiment, the fluid held in reservoir 40 is a radiopaque coolant fluid. As stated briefly above, by using a relatively cool fluid to inflate
balloon 22, the tube 30 andballoon 22 serve to provide a so-called heat-sink to further reduce the risk of perforating or otherwise damaging the esophagus during ablation of theheart 18. - The coolant also preferably is radiopaque, such as having been treated with a radiopaque dye of the kind known in the art. In this manner, the esophagus 14 is readily visible using X-rays or other imaging techniques while the fluid is flowing through the tube 30 while tube 30 is inserted into the esophagus 14. Accordingly, the operator carrying out the procedure is able to view the esophagus 14 during inflation of
balloon 22 such that he or she may better observe the location of the esophagus 14 with respect to theheart 18 and, in particular, the left atrium 24 of the heart. Thus, the operator is able to determine whether esophagus 14 has been moved sufficiently far from theheart 18 such that he or she may safely perform an ablation thereon. A radio-opaque fluid also permits the ablation process to be imaged without obstruction from theballoon 22. - With particular reference to
FIG. 5 , one embodiment of the invention is shown in which a number ofelectrodes 42 are inserted into theballoon 22 via tube 30. In particular,electrodes 42 are disposed within the wall ofballoon 22.Electrodes 42 are coupled to a power source 44 (seeFIG. 7 ) by way of anelectrical conductor 46, which extends upwardly through tube 30 and out of the tube 30 for interconnection with power source 44. Power source 44 may be an electrical connection assembly of the kind known in the art configured to supply a predetermined amount of electricity to theelectrodes 42. Theelectrodes 42 by way ofconductor 46 may be interfaced with a three-dimensional electro-anatomical mapping system of the kind generally known in the art. In this manner,balloon 22 is capable of being viewed by the operator at a display screen in three-dimensions. Thus,balloon 22 may be viewed in relation to the ablation site onheart 18 at any given time. Alternatively,electrodes 42 may be replaced by magnetic dipoles that allow the location of theballoon 22 to be detected using a magnetically-based three-dimensional mapping system such as CARTO 3D or a similar known system. - Alternatively, or in addition to,
electrodes 42,balloon 22 may include a number of temperature sensors 47 incorporated into theballoon 22 cavity or wall. The temperature sensors may be interconnected with a temperature monitoring assembly such that the operator may be able to determine a temperature of theballoon 22 during ablation of left atrium 24 ofheart 18. In one embodiment of the invention, if the temperature exceeds a predetermined value, thesystem 20 of the invention may be configured to automatically respond. For example,system 20 may be configured to respond to prevent a lesion from forming or expanding by flooding theballoon 22 with additional fluid When a particular predetermined temperature is detected. Thesystem 20 may be interfaced with the power source of the ablation mechanism such that the ablation itself is also terminated. - In operation,
balloon 22 is introduced into the esophagus 14 through the oral cavity 13 via the mouth 12 to a location in which it is substantially adjacent to, and preferably parallel with, the left atrium 24 ofheart 18, It is positioned such that thestiffening strip 34 is located adjacent a portion of the esophagus that is relatively close to the heart. Accordingly, whenballoon 22 is inflated asymmetrically but circumferentially, the adjacent portion of the esophagus 14 will be moved away from theheart 18. More specifically, the operator actuates pump 38 and/or related controls to supply pressurized fluid into the tube 30 and thence intoballoon 22. Asballoon 22 begins to inflate with the introduction of the fluid thereto, theballoon 22 expands asymmetrically in the direction of theflexible portion 48 thereof As can be seen from a review ofFIG. 4 , the expansion of theflexible portion 48 ofballoon 22 causes theballoon 22 to bow or bend in the direction of the expansion, eventually contacting the sidewall of the esophagus adjacent thereto. As theflexible portion 48 continues to expand, it begins to exert a force on the esophagus 14 such that esophagus 14 moves in a direction of the applied force or away from theheart 18. In this manner, as can best be seen fromFIG. 2 , the esophagus becomes bowed at or about the regionadjacent heart 18 to move directly away from or sideways relative to the left atrium such that the caregiver is free to begin the ablation of left atrium 24 ofheart 18. If theballoon 22 is configured and oriented such that, when the balloon is inflated, the esophagus 14 moves sideways away from the ablation site to interpose itself between the phrenic nerve and the left atrial lesion, the esophagus 14 can provide a barrier or protection against accidental damage to the phrenic nerve. At its maximum point of distortion, the esophagus preferably moves at least 5 mm, and more preferably at least 20 mm, laterally away from its initial position. - When the fluid used to inflate the balloon is a coolant, the coolant in the
balloon 22 also serves as a heat sink sufficient to mitigate or even prevent injury to the phrenic nerve, orballoon 22 may assist in mobilizing the nerve such that it is positioned out of the way of the ablation site. - After the ablation procedure is complete, the
balloon 22 is deflated by operation of the relief valve 32 or otherwise and removed from the esophagus. - Although the best mode contemplated by the inventors of carrying out the present invention is disclosed above, practice of the present invention is not limited thereto. It will be manifest that various additions, modifications and rearrangements of the aspects and features of the present invention may be made in addition to those described above without deviating from the spirit and scope of the underlying inventive concept. The scope of some of these changes is discussed above. The scope of other changes to the described embodiments that fall within the present invention but that are not specifically discussed above will become apparent from the appended claims and other attachments.
Claims (16)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/786,707 US10661060B2 (en) | 2009-10-06 | 2017-10-18 | Method of using an intra-esophageal balloon system |
US16/007,461 US11497899B2 (en) | 2009-10-06 | 2018-06-13 | Intra-esophageal balloon system |
US17/962,889 US20230111733A1 (en) | 2009-10-06 | 2022-10-10 | Intra-Esophageal Balloon System |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27256409P | 2009-10-06 | 2009-10-06 | |
US12/847,018 US9937329B2 (en) | 2009-10-06 | 2010-07-30 | Intra-esophageal balloon system |
US15/786,707 US10661060B2 (en) | 2009-10-06 | 2017-10-18 | Method of using an intra-esophageal balloon system |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/847,018 Division US9937329B2 (en) | 2009-10-06 | 2010-07-30 | Intra-esophageal balloon system |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/007,461 Continuation-In-Part US11497899B2 (en) | 2009-10-06 | 2018-06-13 | Intra-esophageal balloon system |
Publications (2)
Publication Number | Publication Date |
---|---|
US20180050181A1 true US20180050181A1 (en) | 2018-02-22 |
US10661060B2 US10661060B2 (en) | 2020-05-26 |
Family
ID=43823786
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/847,018 Active 2033-07-08 US9937329B2 (en) | 2009-10-06 | 2010-07-30 | Intra-esophageal balloon system |
US15/786,707 Active 2031-06-23 US10661060B2 (en) | 2009-10-06 | 2017-10-18 | Method of using an intra-esophageal balloon system |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/847,018 Active 2033-07-08 US9937329B2 (en) | 2009-10-06 | 2010-07-30 | Intra-esophageal balloon system |
Country Status (1)
Country | Link |
---|---|
US (2) | US9937329B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109452961A (en) * | 2018-06-07 | 2019-03-12 | 上海科赐医疗技术有限公司 | It is bent foley's tube pull device |
CN109480925A (en) * | 2017-09-11 | 2019-03-19 | 上海科库医疗技术有限公司 | A kind of bending balloon catheter retractor and its retract method |
CN110192901A (en) * | 2018-02-27 | 2019-09-03 | 上海科赐医疗技术有限公司 | Sacculus pulling device and its manufacturing method |
CN111065358A (en) * | 2017-08-10 | 2020-04-24 | 贝利斯医疗公司 | Heat exchange and temperature sensing device and method of use thereof |
CN115487402A (en) * | 2021-06-18 | 2022-12-20 | 上海科赐医疗技术有限公司 | Anti-torsion bending balloon device |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2579943B1 (en) * | 2010-06-10 | 2019-11-13 | Myriad Medical LLC | Intracavity balloon catheter |
WO2013134701A2 (en) * | 2012-03-09 | 2013-09-12 | Clearstream Technologies Limited | Medical balloon with multi-position actuator for precisely arranging the working surface |
US9204993B2 (en) | 2013-01-15 | 2015-12-08 | Empire Technology Development Llc | Treatment of diverticula |
US9623213B2 (en) | 2013-03-15 | 2017-04-18 | Acclarent, Inc. | Uncinate process support for ethmoid infundibulum illumination |
US9615959B2 (en) | 2013-03-15 | 2017-04-11 | Acclarent, Inc. | Uncinate process support for ethmoid infundibulum illumination |
US10695041B2 (en) * | 2014-02-28 | 2020-06-30 | Manual Surgical Sciences Llc | Expandable devices for positioning organs |
EP3110493A4 (en) * | 2014-02-28 | 2017-11-01 | Manual Surgical Sciences, LLC | Expandable devices for positioning organs |
US11419656B2 (en) | 2014-04-04 | 2022-08-23 | Cpsi Holdings Llc | Thermal regulation catheter system |
US10206595B2 (en) | 2014-11-17 | 2019-02-19 | 3VO Medical, Inc. | Intrauterine balloon apparatus, system, and method for augmenting uterine birthing forces during parturition |
US10898091B2 (en) | 2015-02-02 | 2021-01-26 | Northwestern University | Systems, methods, and apparatus for esophageal panometry |
DE102015103213A1 (en) * | 2015-03-05 | 2016-09-08 | Medfact Engineering Gmbh | Device for displacing a hollow organ of a patient |
US11160569B2 (en) | 2015-09-17 | 2021-11-02 | Texas Heart Institute | Esophageal probes and methods |
US11045251B2 (en) * | 2016-06-15 | 2021-06-29 | Steven W. Miller | Gastric tube for ablation procedures |
EP3544666A4 (en) * | 2016-11-23 | 2020-09-02 | Innovations in Medicine, LLC | System and method for deflection of a body lumen |
US20180310989A1 (en) * | 2017-04-28 | 2018-11-01 | Rex Medical, L.P. | Esophageal retractor with sensor |
WO2019040789A1 (en) | 2017-08-23 | 2019-02-28 | Manual Surgical Sciences, LLC | Expandable devices for positioning organs |
JP6755630B2 (en) * | 2017-09-06 | 2020-09-16 | 日本ライフライン株式会社 | catheter |
JP2021511933A (en) * | 2018-01-23 | 2021-05-13 | イー−セーフ メディカル,インコーポレイテッド | Esophageal probe and method |
CN108096676B (en) * | 2018-01-31 | 2023-09-29 | 重庆医科大学 | Gasbag management formula breathing machine |
WO2019174708A1 (en) * | 2018-03-12 | 2019-09-19 | Dr. Philippe Debruyne Bvba | Device for deflecting an esophagus of a patient away from a treatment area outside of the esophagus |
US11744993B2 (en) | 2021-07-19 | 2023-09-05 | Innovations In Medicine, Llc | System and method for deflection mechanism with expandable constraint |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2077453A (en) | 1934-03-29 | 1937-04-20 | American Anode Inc | Therapeutical appliance |
US4955377A (en) * | 1988-10-28 | 1990-09-11 | Lennox Charles D | Device and method for heating tissue in a patient's body |
US5048532A (en) * | 1989-09-18 | 1991-09-17 | State University Of New York | Method and apparatus for measuring blood pressure |
US5170803A (en) * | 1990-09-28 | 1992-12-15 | Brunswick Biomedical Technologies, Inc. | Esophageal displacement electrode |
US5766151A (en) * | 1991-07-16 | 1998-06-16 | Heartport, Inc. | Endovascular system for arresting the heart |
US5626618A (en) * | 1993-09-24 | 1997-05-06 | The Ohio State University | Mechanical adjunct to cardiopulmonary resuscitation (CPR), and an electrical adjunct to defibrillation countershock, cardiac pacing, and cardiac monitoring |
US5558665A (en) * | 1994-06-24 | 1996-09-24 | Archimedes Surgical, Inc. | Surgical instrument and method for intraluminal retraction of an anatomic structure |
US5716386A (en) * | 1994-06-27 | 1998-02-10 | The Ohio State University | Non-invasive aortic impingement and core and cerebral temperature manipulation |
US5662608A (en) * | 1995-07-26 | 1997-09-02 | Intelliwire, Inc. | Low profile balloon catheter and method |
US6217548B1 (en) | 1996-05-14 | 2001-04-17 | Embol-X, Inc. | Cardioplegia balloon cannula |
US6015382A (en) * | 1997-10-16 | 2000-01-18 | General Surgical Innovations, Inc. | Inflatable manipulator for organ positioning during surgery and method of use |
US6146339A (en) * | 1999-05-24 | 2000-11-14 | Advanced Cardiovascular Systems | Guide wire with operator controllable tip stiffness |
US7040322B2 (en) | 2001-11-08 | 2006-05-09 | Fortuna Anibal De Oliveira | Combination artificial airway device and esophageal obturator |
US20030144682A1 (en) | 2002-01-30 | 2003-07-31 | Qureshi Adnan I. | Cardiac compression device, kit, and method of using same |
US7758623B2 (en) | 2003-03-17 | 2010-07-20 | The Board Of Trustees Of The Leland Stanford Junior University | Transesophageal heat exchange catheter for cooling of the heart |
US7101387B2 (en) | 2003-04-30 | 2006-09-05 | Scimed Life Systems, Inc. | Radio frequency ablation cooling shield |
US20060118127A1 (en) | 2004-12-06 | 2006-06-08 | Chinn Douglas O | Tissue protective system and method for thermoablative therapies |
EP1933787A1 (en) | 2005-08-19 | 2008-06-25 | Werner Francois De Neve | Device and method for assisting heat ablation treatment of the heart |
US20070055328A1 (en) | 2005-09-02 | 2007-03-08 | Mayse Martin L | Device and method for esophageal cooling |
DE102006044659A1 (en) | 2005-09-21 | 2007-03-22 | Siemens Ag | Temperature measuring device to be inserted into esophagus to be slightly moved for heart operation, comprises balloon with temperature sensors and operating cable |
US9931108B2 (en) | 2005-11-18 | 2018-04-03 | Steven Miller | System and method for influencing an anatomical structure |
US7621908B2 (en) | 2005-11-18 | 2009-11-24 | Miller Steven W | Catheter for manipulation of the esophagus |
US8273016B2 (en) * | 2006-03-10 | 2012-09-25 | Biosense Webster, Inc. | Esophagus isolation device |
US8454588B2 (en) | 2006-03-17 | 2013-06-04 | The Board Of Trustees Of The Leland Stanford Junior University | Method and apparatus to prevent esophageal damage |
US20080125708A1 (en) | 2006-05-30 | 2008-05-29 | Da-Li Feng | Intra-pericardial protective device |
RU2417732C2 (en) * | 2006-10-10 | 2011-05-10 | Байосенс Уэбстер, Инк. | Oesophageal mapping catheter |
US20080161890A1 (en) | 2007-01-03 | 2008-07-03 | Boston Scientific Scimed, Inc. | Methods, systems, and apparatuses for protecting esophageal tissue during ablation |
US8512387B2 (en) | 2007-09-07 | 2013-08-20 | Robert S. Fishel | Esophageal cooling system for ablation procedures associated with cardiac arrhythmias |
-
2010
- 2010-07-30 US US12/847,018 patent/US9937329B2/en active Active
-
2017
- 2017-10-18 US US15/786,707 patent/US10661060B2/en active Active
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111065358A (en) * | 2017-08-10 | 2020-04-24 | 贝利斯医疗公司 | Heat exchange and temperature sensing device and method of use thereof |
CN109480925A (en) * | 2017-09-11 | 2019-03-19 | 上海科库医疗技术有限公司 | A kind of bending balloon catheter retractor and its retract method |
CN110192901A (en) * | 2018-02-27 | 2019-09-03 | 上海科赐医疗技术有限公司 | Sacculus pulling device and its manufacturing method |
CN109452961A (en) * | 2018-06-07 | 2019-03-12 | 上海科赐医疗技术有限公司 | It is bent foley's tube pull device |
CN115487402A (en) * | 2021-06-18 | 2022-12-20 | 上海科赐医疗技术有限公司 | Anti-torsion bending balloon device |
Also Published As
Publication number | Publication date |
---|---|
US20110082488A1 (en) | 2011-04-07 |
US9937329B2 (en) | 2018-04-10 |
US10661060B2 (en) | 2020-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10661060B2 (en) | Method of using an intra-esophageal balloon system | |
US10390872B2 (en) | Multifunctional ablation device | |
US7189227B2 (en) | Cryo balloon | |
US11648043B2 (en) | Accessory to allow sensing at balloon interface | |
CN108430301B (en) | Esophageal probes and methods | |
US9636172B2 (en) | Compliant balloon with liquid injection | |
US8540666B2 (en) | Echogenic occlusive balloon and delivery system | |
US20070055328A1 (en) | Device and method for esophageal cooling | |
EP2528527B1 (en) | Partially compliant balloon device | |
JP2017217473A (en) | Balloon catheter, and impedance-based methods for detecting occlusion related to balloon catheter | |
US20060224153A1 (en) | Catheter system for the treatment of atrial fibrillation | |
US20160278845A1 (en) | System and method for pulmonary treatment | |
US20150150624A1 (en) | Device For Therapeutic Delivery of Radio Frequency Energy | |
EP2967726A1 (en) | Steerable ablation device with linear ionically conductive balloon | |
WO2010078875A1 (en) | Ablation balloon catheter | |
US20230111733A1 (en) | Intra-Esophageal Balloon System | |
US20190307499A1 (en) | Ablation device having a sheath with a dilatable member for fixation and/or support of an ablation applicator, and method of operating an ablation device | |
EP3573526B1 (en) | Highly flexible mapping and treatment device | |
WO2018065047A1 (en) | Method for protecting a patient's esophagus while ablating tissue of the patient's heart and intra-esophageal system therefor | |
US20240207587A1 (en) | Rapid depressurization of irrigated balloon catheter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NIAZI LICENSING CORPORATION, WASHINGTON Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NIAZI, IMRAN K.;REEL/FRAME:043890/0062 Effective date: 20170829 |
|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: AWAITING TC RESP, ISSUE FEE PAYMENT RECEIVED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: AWAITING TC RESP, ISSUE FEE PAYMENT VERIFIED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: AWAITING TC RESP, ISSUE FEE PAYMENT VERIFIED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: NIAZI PATENT HOLDINGS, LLC, WISCONSIN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NIAZI LICENSING CORPORATION;REEL/FRAME:055874/0412 Effective date: 20210409 |
|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |